2019
DOI: 10.1016/j.msec.2019.109954
|View full text |Cite
|
Sign up to set email alerts
|

An in situ slow-releasing H2S donor depot with long-term therapeutic effects for treating ischemic diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 44 publications
0
14
0
Order By: Relevance
“…For example, it is suggested that DATS could be used for the treatment of I/R injury in brain tissues for its inhibitory effects on oxidative stress through Nrf2 activation ( Silva-Islas et al, 2019 ). Besides, DATS is also believed to own the ability for the promotion of angiogenesis ( Hayashida et al, 2017 ), which can be utilized for the protection of ischemic tissue in diabetic mice ( Yang et al, 2018 ) as well as the salvation of the ischemic limb ( Hsieh et al, 2019 ). In addition, there is a report suggesting that DATS is involved in the interruption of cell apoptosis through the induction of autophagy ( Chu et al, 2012 ).…”
Section: Introductionmentioning
confidence: 99%
“…For example, it is suggested that DATS could be used for the treatment of I/R injury in brain tissues for its inhibitory effects on oxidative stress through Nrf2 activation ( Silva-Islas et al, 2019 ). Besides, DATS is also believed to own the ability for the promotion of angiogenesis ( Hayashida et al, 2017 ), which can be utilized for the protection of ischemic tissue in diabetic mice ( Yang et al, 2018 ) as well as the salvation of the ischemic limb ( Hsieh et al, 2019 ). In addition, there is a report suggesting that DATS is involved in the interruption of cell apoptosis through the induction of autophagy ( Chu et al, 2012 ).…”
Section: Introductionmentioning
confidence: 99%
“…Genetic ablation of NRF2 suppresses the proliferation and angiogenic function of endothelial cells in vitro and in vivo [43]. Furthermore, in the preclinical model of ischemic retinopathy, cerebral ischemia, and HLI, knockdown of NRF2 limits the effectiveness of angiogenesis therapy [72][73][74]. Importantly, the activation of NRF2 could promote the expression of angiogenic genes in wound biopsies in diabetic patients [75].…”
Section: Discussionmentioning
confidence: 99%
“…H 2 S has shown the abilities to relieve oxidative stress [ 177 ], promote angiogenesis [ 16 ], and inhibit cellular apoptosis [ 178 ], which are benefit for treating ischemia. In an attempt to treat limb ischemia, Sung et al prepared DATS loaded H 2 S releasing PLGA microparticles (DATS@MPs) through an oil-in-water single emulsion method [ 68 ]. Compared with free DATS, DATS@MPs enabled prolonged intracellular H 2 S generation, favoring long-lasting therapeutic effects.…”
Section: Therapeutic Applications Of Intelligent Polymeric H ...mentioning
confidence: 99%